Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Cygro 1% Premix 10 g Drug Premix is a Health Canada–registered veterinary drug (DIN 02230778) held by Hoffmann-La Roche Limited, containing Maduramicin Ammonium. Health Canada lists its status as Cancelled Post Market (status date 27 Jul 2000). Nexara Health has matched 2 registrations of Maduramicin Ammonium across 1 other regulated market.

Health Canada registration

DIN02230778
Brand nameCygro 1% Premix
Active ingredientMaduramicin Ammonium
Strength10 g
Dosage formDrug Premix
RouteOral
CompanyHoffmann-La Roche Limited
StatusCancelled Post Market — 27 Jul 2000
ClassVeterinary
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Maduramicin Ammonium registered in other markets

2 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
MalaysiaMaduramicin Ammonium Premix 1% PowderWeissen Company (m) Sdn. Bhd.VeterinaryPRODUCT APPROVEDNPRA
MalaysiaPf Maduramicin Premix 1% W/W PowderPanfast Marketing (m) Sdn BhdVeterinaryPRODUCT APPROVEDNPRA

See every manufacturer of Maduramicin Ammonium worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Cygro 1% Premix (DIN 02230778) marketed in Canada?

No. Health Canada lists DIN 02230778 as Cancelled Post Market as of 27 Jul 2000.

Who holds the Canadian licence for this product?

Hoffmann-La Roche Limited is the company of record in the Health Canada Drug Product Database.

Is Maduramicin Ammonium registered outside Canada?

Yes — Nexara Health has matched 2 registrations in 1 other market (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02230778, status date 2000-07-27; national medicine registries: NPRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02230778, status date 2000-07-27; national medicine registries: NPRA.

Health Canada Drug Product Database (DPD), DIN 02230778, status date 2000-07-27; national medicine registries: NPRA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.